On average, symptoms started earlier in people with DM1 than DM2 (24.9 vs. Patients treated with human insulin A patient pre-screening register will be set up in each centre to establish the reasons for DM1/DM2 patients treated with a basal-bolus insulin regimen who are not taking part in the study. Various clinical features between the two diseases were compared.Patients who are pregnant or who wish to become pregnant during the study.Participation in a clinical study within 6 months, except for the Meos (or télédiab 3) study after a participation period of 6 months.Patients who have used the DIABEO system within 6 months before inclusion.Subject affiliated to the French National Health Insurance funds or benefiting from such insurance Furthermore, comparison of the pain and myotonia in DM1 and DM2 separately revealed no significant difference in the frequency of pain between groups with and.Who have given their signed consent to take part in the study Myotonic dystrophy (DM) is a complex multisystemic disorder linked to two different genetic loci.Who are able to understand and follow the study protocol.Whose HbA1c dating of less 1 month and more than 3 months is ≥ 8%.Who have an Apple® or Androïde® Smartphone compatible, or intend to acquire one before their participation in the study.Treated with insulin by a basal-bolus regimen for at least 1 year and using the same method of administration for at least 3 months (insulin pen or pump).Performing auto-glycaemic control (at least 2 glycemias a day).Why Should I Register and Submit Results?.
0 Comments
Leave a Reply. |